News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jacobs Bruce N.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 05/03/2022 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $2.08, valued at
$41.6k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 01/14/2022 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 6,427 shares
@ $51.2135, valued at
$329.1k
Sold 7,151 shares
@ $52.1309, valued at
$372.8k
Sold 1,422 shares
@ $53.2678, valued at
$75.7k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 6,881 shares
@ $44.1231, valued at
$303.6k
Sold 12,019 shares
@ $45.0703, valued at
$541.7k
Sold 1,100 shares
@ $45.748, valued at
$50.3k
Exercised 20,000 options to buy
@ $2.08, valued at
$41.6k
|
|
| 03/03/2021 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $48.46, valued at
$6.8M
|
|
| 08/21/2020 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 32,904 options to buy
@ $20, valued at
$658.1k
|
|
| 08/20/2020 |
3
| Jacobs Bruce N. (CFO) has filed a Form 3 on Kymera Therapeutics, Inc. |
|
|